Nexium Capsules RE Maintenance Specific Clinical Experience Investigation

Overview

The purpose of this study is to collect following data in patients given Nexium capsule (Nexium) in usual post-marketing use as the maintenance therapy for repeatedly recurring/relapsing reflux oesophagitis.

Full Title of Study: “Nexium Capsules Specific Clinical Experience Investigation for Maintenance Therapy for Repeatedly Recurring/Relapsing Reflux Oesophagitis”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: July 2014

Detailed Description

Nexium capsules Specific Clinical Experience Investigation for Maintenance Therapy for Repeatedly Recurring/Relapsing Reflux Oesophagitis

Arms, Groups and Cohorts

  • Nexium

Clinical Trial Outcome Measures

Primary Measures

  • Number of Adverse Drug Reactions
    • Time Frame: 6 Month
    • Adverse event incidence

Secondary Measures

  • Non-recurrence rate of reflux oesophagitis
    • Time Frame: 6 Month

Participating in This Clinical Trial

Inclusion Criteria

  • Patients with repeatedly recurring/relapsing reflux oesophagitis who will be given Nexium for the first time as a maintenance therapy. Exclusion Criteria:

  • Patients having reflux oesophagitis when Nexium is started (Grade A, Grade B, Grade C or Grade D of Los Angeles Classification (Hoshihara's modification) on endoscopy) – Patients having previous history of maintenance therapy for repeatedly recurring/ relapsing reflux oesophagitis

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • AstraZeneca
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Shigeru Yoshida, MD, Study Director, AstraZeneca K.K.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.